New approaches to symptomatic treatments for Alzheimer's disease.

Mol Neurodegener · 2021 · PMC7805095 · PMID 33441154

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In a 9 month trial conducted in China, participants evidenced a significant improvement above baseline on the ADAS-cog and showed a trend for improvement on the Clinical Interview Based Impression of Change with caregiver input (CIBIC+).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.